Top of this page
Skip navigation, go straight to the content
Executive Committee
Jean-Christophe Tellier
Chief Executive Officer and
Chairman of the Executive Committee
Joined UCB in June 2011
Appointed as CEO in January 2015
Emmanuel Caeymaex
Executive Vice President
Head of Immunology Solutions
Joined UCB in March 1994
Appointed in February 2015
Jean-Luc Fleurial
Executive Vice President
Chief Talent Officer
Joined UCB in September 2017
Appointed in September 2017
Iris Loew-Friedrich
Executive Vice President
Chief Medical Officer
Joined UCB in September 2006
Appointed in March 2008
Kirsten Lund-Jurgensen
Executive Vice President
Head of Supply & Technology Unit
Joined UCB in 2019
Appointed in September 2019
Alexander Moscho
Executive Vice President
Chief Strategy Officer
Joined UCB in October 2017
Appointed in October 2017
Dhavalkumar Patel
Executive Vice President
Chief Scientific Officer
Joined UCB in October 2017
Appointed in October 2017
Pascale Richetta
Executive Vice President
Head of the Bone Patient Value
Unit
Joined UCB in February 2016
Appointed in February 2016
Bill Silbey
Executive Vice President
General Counsel
Joined UCB in 2011
Appointed in March 2019
Bharat Tewarie
Executive Vice President
Chief Marketing Officer
Joined UCB in March 2015
Appointed in March 2015
Detlef Thielgen
Executive Vice President
Chief Financial Officer
Joined UCB in September 2006
Appointed in January 2007
Charl van Zyl
Executive Vice President
Head of Neurology Solutions
Joined UCB in March 2017
Appointed in March 2017
Jeff Wren
Executive Vice President
Neurology – Patient Value Unit Head
Joined UCB in 2010
Appointed in February 2015
Leaving on October 31, 2019 and handing over to Charl van Zyl